1. Medtech Insight
  2. >>Geography
  3. >>North America
  4. >>United States

Tandem Diabetes Adds Special Touch (Screen) To Integrated Pump-Monitor Space

Tandem Diabetes Care’s t:slim G4 insulin pump/continuous glucose monitor system is the latest DexCom partnership to yield an FDA approval, and the first integrated diabetes system to feature a touch-screen display.

The novel field of insulin pumps with integrated continuous glucose monitoring (CGM) gained another U.S. competitor as San Diego-based Tandem Diabetes Care Inc. announced FDA approval of the t:slim G4 insulin pump/CGM system .

The t:slim, which may be used by insulin-dependent diabetics age 12 and over, is the first such pump-CGM combination to include a touch-screen that displays glucose graphs and trend information,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America